Effect of annatto-tocotrienols supplementation on the Development of Mammary Tumors in HER-2/neu Transgenic Mice

被引：0
|
作者：
Pierpaoli, E. [1 ]
Viola, V. [1 ]
Barucca, A. [1 ]
Orlando, F. [1 ]
Galli, F. [1 ]
Provinciali, M. [1 ]
机构：
[1] Univ Perugia, I-06100 Perugia, Italy
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2012年 / 53卷
关键词：
Desmethylated tocotrienols; Mammary tumors; Cancer therapy; HER-2/neu transgenic mice;
D O I：
10.1016/j.freeradbiomed.2012.08.518
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [41] Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice
    Lollini, PL
    Nicoletti, G
    Landuzzi, L
    De Giovanni, C
    Rossi, I
    Di Carlo, E
    Musiani, P
    Muller, WJ
    Nanni, P
    INTERNATIONAL JOURNAL OF CANCER, 1998, 77 (06) : 937 - 941
  • [42] Expression of HER-2/neu in testicular tumors
    Mandoky, L
    Geczi, L
    Bodrogi, I
    Toth, J
    Bak, M
    ANTICANCER RESEARCH, 2003, 23 (04) : 3447 - 3451
  • [43] Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors
    Worschech, Andrea
    Kmieciak, Maciej
    Knutson, Keith L.
    Bear, Harry D.
    Szalay, Aladar A.
    Wang, Ena
    Marincola, Francesco M.
    Manjili, Masoud H.
    CANCER RESEARCH, 2008, 68 (07) : 2436 - 2446
  • [44] Signatures Associated With Rejection or Recurrence in HER-2/Neu-positive Mammary Tumors
    Worschech, Andrea
    Kmieciak, Maciej
    Knutson, Keith L.
    Bear, Harry D.
    Szalay, Aladar A.
    Wang, Ena
    Marincola, Francesco
    Manjib, Masoud H.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 1011 - 1011
  • [45] Protective Effect of mTOR Inhibitor Rapamycin during Doxorubicin Treatment in Transgenic HER-2/neu Mice
    Yurova, Maria N.
    Gubareva, Ekaterina A.
    Tyndyk, Margarita L.
    CELL DEATH DISCOVERY, 2020, 6 (01)
  • [46] Mammary Tumors in HER-2/NEU Mice Are Characterized by Low Content of Estrogen Receptors-α and Absence of Progesterone Receptors
    L. M. Bershtein
    I. N. Alimova
    E. V. Tsyrlina
    V. N. Anisimov
    Bulletin of Experimental Biology and Medicine, 2003, 135 : 580 - 581
  • [47] Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-a and absence of progesterone receptors
    Bershtein, LM
    Alimova, IN
    Tsyrlina, EV
    Anisimov, VN
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 135 (06) : 580 - 581
  • [48] Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice
    Di Carlo, E
    Rovero, S
    Boggio, K
    Quaglino, E
    Amici, A
    Smorlesi, A
    Forni, G
    Musiani, P
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 830S - 837S
  • [49] Prevention by delay: Nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice
    Cavallo, F
    Di Carlo, E
    Quaglino, E
    Iezzi, M
    Strasly, M
    Bussolino, F
    Colombo, MR
    Nanni, R
    Lollini, PL
    Musiani, P
    Forni, G
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (04): : 351 - 358
  • [50] Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice
    Nanni, P
    Nicoletti, G
    De Giovanni, C
    Landuzzi, L
    Di Carlo, E
    Cavallo, F
    Pupa, SM
    Rossi, I
    Colombo, MP
    Ricci, C
    Astolfi, A
    Musiani, P
    Forni, G
    Lollini, PL
    JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09): : 1195 - 1205
12345